IRIS
FIORE, MICHELE
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 7.401
NA - Nord America 1.998
EU - Europa 1.160
SA - Sud America 231
AF - Africa 42
OC - Oceania 10
Continente sconosciuto - Info sul continente non disponibili 1
Totale 10.843
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 6.100
US - Stati Uniti d'America 1.906
CN - Cina 660
IT - Italia 582
HK - Hong Kong 211
BR - Brasile 154
VN - Vietnam 119
DE - Germania 113
FR - Francia 110
BD - Bangladesh 107
GB - Regno Unito 107
IN - India 64
FI - Finlandia 44
EE - Estonia 43
CA - Canada 42
NL - Olanda 41
ID - Indonesia 31
AR - Argentina 29
MX - Messico 25
AT - Austria 18
ZA - Sudafrica 17
IQ - Iraq 15
SE - Svezia 14
JP - Giappone 13
UA - Ucraina 13
EC - Ecuador 12
ES - Italia 12
TR - Turchia 12
CZ - Repubblica Ceca 11
CL - Cile 10
RU - Federazione Russa 10
SA - Arabia Saudita 10
AU - Australia 9
RO - Romania 9
CO - Colombia 8
PK - Pakistan 8
PH - Filippine 7
UZ - Uzbekistan 7
PL - Polonia 6
VE - Venezuela 6
KZ - Kazakistan 5
MY - Malesia 5
DZ - Algeria 4
GT - Guatemala 4
IL - Israele 4
JM - Giamaica 4
LT - Lituania 4
MA - Marocco 4
MD - Moldavia 4
PE - Perù 4
PY - Paraguay 4
BE - Belgio 3
BG - Bulgaria 3
CR - Costa Rica 3
EG - Egitto 3
KE - Kenya 3
NI - Nicaragua 3
PT - Portogallo 3
TW - Taiwan 3
BH - Bahrain 2
CM - Camerun 2
ET - Etiopia 2
HT - Haiti 2
LB - Libano 2
LY - Libia 2
NP - Nepal 2
OM - Oman 2
PS - Palestinian Territory 2
SK - Slovacchia (Repubblica Slovacca) 2
UY - Uruguay 2
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BO - Bolivia 1
BY - Bielorussia 1
CH - Svizzera 1
CY - Cipro 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GF - Guiana Francese 1
GP - Guadalupe 1
HN - Honduras 1
HU - Ungheria 1
IE - Irlanda 1
JO - Giordania 1
KR - Corea 1
KW - Kuwait 1
LV - Lettonia 1
ML - Mali 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
PA - Panama 1
RE - Reunion 1
RS - Serbia 1
SL - Sierra Leone 1
SY - Repubblica araba siriana 1
TG - Togo 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 10.837
Salva come PNG Salva come JPEG
Città #
San Jose 677
Singapore 470
Rome 390
Ashburn 345
Hong Kong 205
Beijing 201
Hefei 200
Dallas 168
Lauterbourg 93
London 84
Boardman 83
Munich 68
Shanghai 67
Council Bluffs 59
New York 53
Los Angeles 46
Ho Chi Minh City 44
Santa Clara 39
Amsterdam 29
Hanoi 26
Helsinki 23
Milan 21
Turku 21
San Francisco 20
São Paulo 19
Sona 14
Toronto 14
Washington 14
Orem 13
Brooklyn 12
Chennai 12
Mexico City 12
Pune 12
Atlanta 11
Las Vegas 11
Naples 11
Boston 10
Chicago 10
Brno 9
Seattle 9
Tokyo 9
Frankfurt am Main 8
Nuremberg 8
West Jordan 8
Buffalo 7
Guangzhou 7
Hangzhou 7
Palermo 7
Rio de Janeiro 7
Tashkent 7
Haiphong 6
Jakarta 6
Johannesburg 6
Montreal 6
Redmond 6
Ankara 5
Baghdad 5
Buenos Aires 5
Denver 5
Guayaquil 5
Hải Dương 5
New Delhi 5
Rocca di Papa 5
Bari 4
Cascina 4
Catania 4
Dhaka 4
Lima 4
Miami 4
Pasadena 4
Phoenix 4
Quito 4
St Louis 4
Sumaré 4
Umeå 4
Vicenza 4
Vienna 4
Warsaw 4
Aprilia 3
Bologna 3
Bucharest 3
Bình Dương 3
Cagliari 3
Central 3
Genoa 3
Guatemala City 3
Handan 3
Hanover 3
Houston 3
Innsbruck 3
Kuala Lumpur 3
Lahore 3
Ludhiana 3
Madrid 3
Managua 3
Manchester 3
Medina 3
Melbourne 3
Mumbai 3
Nairobi 3
Totale 3.896
Salva come PNG Salva come JPEG
Nome #
18F-choline PET/CT driven salvage radiotherapy in prostate cancer patients: up-date analysis with 5-year median follow-up 342
Deep pathomics: A new image-based tool for predicting response to treatment in stage III non-small cell lung cancer 276
NEW TECHNOLOGIES IN RADIOTHERAPY FOR PROSTATE CANCER: FEASIBILITY, DOSIMETRIC ASPECTS AND CLINICAL RESULTS IN PATIENTS WITH AT LEAST 5-YEAR FOLLOW-UP 253
A bio-imaging signature as a predictor of clinical outcomes in locally advanced pancreatic cancer 236
A new three-dimensional conformal radiotherapy (3DCRT) technique for large breast and/or high body mass index patients: evaluation of a novel fields assessment aimed to reduce extra–target-tissue irradiation 229
Advances in pre-treatment evaluation of pancreatic ductal adenocarcinoma: a narrative review 227
Implementation of a voluntary deep inspiration breath hold technique (vDIBH) using BrainLab ExacTrac infrared optical tracking system. 221
Exploring Deep Pathomics in Lung Cancer 220
Clinical practice guidelines for diagnosis, treatment and follow-up of exocrine pancreatic ductal adenocarcinoma: Evidence evaluation and recommendations by the italian association of medical oncology (AIOM) 218
QUALITY ASSURANCE FOR CLINICAL PRACTICE IN CERVICAL CANCER BRACHYTHERAPY WITH IR-192 SOURCE: IN VIVO DOSIMETRY WITH QED DIODES 218
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 217
Estimating the value of surgical clips for target volume delineation in external beam partial breast radiotherapy 216
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single-center observational retrospective cohort study 215
Adding ipsilateral V20 and V30 to conventional dosimetric constraints predicts radiation pneumonitis in stage IIIA-B NSCLC treated with combined-modality therapy 213
Radiotherapy for HER 2 Positive Brain Metastases: Urgent Need for a Paradigm Shift 209
Combination of novel systemic agents and radiotherapy for solid tumors - part I: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment efficacy. 209
Delayed surgery after radio-chemotherapy for rectal adenocarcinoma is protective for anastomotic dehiscence: a single centre retrospective analysis 209
Clinical results of stereotactic ablative radiotherapy in the treatment of liver metastases 205
Preventing Cardiotoxicity in Personalized Breast Irradiation 201
Histologic transformation to small-cell lung cancer following gefitinib and radiotherapy in a patient with pulmonary adenocarcinoma. 200
Hypofractionated radiotherapy with concomitant boost for breast cancer: a dose escalation study 196
The role of multiparametric magnetic resonance imaging in the diagnosis of local recurrence after radical prostatectomy and before salvage radiotherapy 187
Concurrent Use of Abemaciclib and Radiotherapy in Metastatic Breast Cancer Patients: A Single-Center Experience 164
BOMB trial: First results of stereotactic radiotherapy to primary breast tumor in metastatic breast cancer patients 157
Ablative Five-Fraction Stereotactic Radiotherapy in Elderly Patients with Pancreatic Cancer: A Single Institution Experience 155
42P Radiation induced pneumonitis in the era of the COVID-19 pandemic: Artificial intelligence for differential diagnosis 140
Long term results of a prospective phase 2 study on volume de-escalation in neoadjuvant chemoradiotherapy of rectal cancer 138
The impact of intensified staging and combined therapies in locally advanced pancreatic cancer: a secondary analysis of prospective studies 135
Early GLS changes detection after chemoradiation in locally advanced non-small cell lung cancer (NSCLC) 131
Phase II study of induction chemotherapy followed by chemoradiotherapy in patients with borderline resectable and unresectable locally advanced pancreatic cancer 130
A Multimodal Ensemble Driven by Multiobjective Optimisation to Predict Overall Survival in Non-Small-Cell Lung Cancer 130
Concurrent radiotherapy with palbociclib or ribociclib for metastatic breast cancer patients: preliminary assessment of toxicity 129
CA19.9 Serum Level Predicts Lymph-Nodes Status in Resectable Pancreatic Ductal Adenocarcinoma: A Retrospective Single-Center Analysis 127
Radiation-induced pneumonitis in the era of the covid-19 pandemic: artificial intelligence for differential diagnosis 127
Beams arrangement in non small-cell lung cancer (NSCLC) according to PTV and dosimetric parameters predictive of pneumonitis 126
Prospective study of cetuximab and gemcitabine in combination with radiation therapy: feasibility and efficacy in locally advanced pancreatic head cancer 123
Breast Volume Is a Predictor of Higher Heart Dose in Whole-Breast Supine Free-Breathing Volumetric-Modulated Arc Therapy Planning 122
Stereotactic Radiation and Dual Human Epidermal Growth Factor Receptor 2 Blockade with Trastuzumab and Pertuzumab in the Treatment of Breast Cancer Brain Metastases: A Single Institution Series 119
Factors predicting pathological response to neoadjuvant chemoradiotherapy in rectal cancer: The experience of a single institution with 269 patients (STONE-01) 118
The psychological impact of the covid-19 pandemic on radiotherapy cancer patients 113
LPS AND RADIATION-INDUCED GUT PERMEABILITY DAMAGE: FOCUS ON THE POTENTIAL BENEFICIAL EFFECT OF GRAPE SEED EXTRACT 112
Addressing the crisis: the looming shortage of radiation oncologists and the urgency for action 109
Different biliary microbial flora influence type of complications after pancreaticoduodenectomy: a single center retrospective analysis 107
A clinical score, including biohumoral parameters, is a useful pretest index to discriminate pulmonary infections from radiation damage in chemoradiation-treated lung cancer patients 106
Novel prognostic groups in thymic epithelial tumors: assessment of risk and therapeutic strategy selection 105
A radiomic approach for adaptive radiotherapy in non-small cell lung cancer patients 104
Chemoradiation for stage III non-small cell lung cancer 103
Doctor-in-the-Loop: An explainable, multi-view deep learning framework for predicting pathological response in non-small cell lung cancer 93
Best practices for the management of thymic epithelial tumors: A position paper by the Italian collaborative group for ThYmic MalignanciEs (TYME). 93
Exploratory Radiomics for Predicting Adaptive Radiotherapy in Non-Small Cell Lung Cancer 86
COVID-19 and radiation induced pneumonitis: Overlapping clinical features of different diseases 81
Radiation treatment for adult rare cancers: Oldest and newest indication 77
Precision radiotherapy by SPECT lung functional imaging in NSCLC 65
Efficacy of a Propolis-Based Syrup (FARINGEL) in Preventing Radiation-Induced Esophagitis in Locally Advanced Lung Cancer. 60
Thoracic Radiotherapy in Extensive Disease Small Cell Lung Cancer: Multicenter Prospective Observational TRENDS Study 58
Special Issue “Hepatobiliary and Pancreatic Cancers: Novel Strategies for of Diagnosis and Treatments” 57
NeoAdjuvant chemoradiation for pancreatic cancer results of an ongoing trial 57
Empowering Hepatocellular Carcinoma Ablative Therapy: A Renaissance of Collaboration 56
In Reply to Riou et al 56
Protective Role of Natural Compounds under Radiation-Induced Injury 56
MULTIMODALITY TREATMENT WITH RADIOCHEMOTHERAPY AND ERLOTINIB IN ADVANCED NSCLC (MARTE TRIAL). 56
Pancreatic cancer care: Lighting the way with the torch of staging laparoscopy and advanced imaging 55
Heterotopic hip ossification resection: monocentric experiences of associated factors, outcomes, and complications 53
Combined modality therapy for thoracic and head and neck cancers: A review of updated literature based on a consensus meeting 53
Breast CancerTrastuzumab-deruxtecan and radiotherapy: a safety sub-analysis of combart prospective cohort study 52
Radiotherapy and vascular endothelial growth factor receptor-tyrosine kinase inhibitors in renal cancer 52
Combination of novel systemic agents and radiotherapy for solid tumors - Part II: An AIRO (Italian association of radiotherapy and clinical oncology) overview focused on treatment toxicity. 52
Local Control and Toxicity of Adaptive Radiotherapy Using Weekly CT Imaging: Results from the LARTIA Trial in Stage III NSCLC 52
Prognostic Score in Radiotherapy Practice for Palliative Treatments (PROPHET) Study for Bone Metastases: An Investigation Into the Clinical Effect on Treatment Prescription 51
The role of stereotactic ablative radiotherapy in oncological and non-oncological clinical settings: Highlights from the 7th Meeting of AIRO - Young Members Working Group (AIRO Giovani) 51
Neutrophil to lymphocyte ratio (NLR) and derived neutrophil to lymphocyte ratio (D-NLR) predict non-responders and postoperative complications in patients undergoing radical surgery after neo-adjuvant radio-chemotherapy for rectal adenocarcinoma 51
Evaluation of Italian radiotherapy research from 1985 to 2005: preliminary analysis 49
In Regard to Parikh et al 48
Protective Effects of Grape Seed Extract on Lipopolysaccharide Exposure and Radiation-Induced Intestinal Mucosal Damage: Insights from an In Vitro Study 46
RADIOCHEMOTHERAPY FOR LOCALLY-ADVANCED NSCLC: WHICH IS THE BEST ASSOCIATION? FROM CHEMOTHERAPY TO BIOLOGICAL TARGET IN 5 PHASES II TRIALS 46
Preliminary results of a phase II study of induction Folfirinox followed by chemoradiation in LAPC 44
Induction chemotherapy with cisplatin, 5-fluorouracil, and cetuximab followed by radiotherapy and cetuximad in head and neck cancers: Preliminary results of a modern integrated approach 44
Molecularly targeted therapy and radiotherapy in the management of localized gastrointestinal stromal tumor (GIST) of the rectum: a case report 44
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer 43
Real-world experience of abiraterone acetate plus prednisone in chemotherapy-naive patients with metastatic castration-resistant prostate cancer: long-term results of the prospective ABItude study 43
OA24.02 - Locally Advanced Non-Small Cell Lung Cancer: RadioTherapy with Adaptive Strategy (LARTIA Trial) 42
Neoadjuvant chemoradiation in locally advanced NSCLC: impact of histology and drugs on results. 42
Clinical Value of Bone Radiotherapy in a Prospective Cohort of Metastatic Breast Cancer Treated with Anti-CDK4/6 41
Safety and efficacy of combined radiotherapy, immunotherapy and targeted agents in elderly patients: A literature review 40
Role of CA 19.9 in the Management of Resectable Pancreatic Cancer: State of the Art and Future Perspectives 40
PV-0276 Adaptive radiotherapy: rate of "marginal" failure after "replanning" in combined treatment of NSCLC. 40
SBRT: A viable option for treating adrenal gland metastases 40
PAIDEIA: pacemaker and implanted cardioverter defibrillator management in radiation therapy—a survey by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO) 39
PATTERN OF FAILURE AFTER ADAPTIVE RADIOCHEMOTHERAPY FOR LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (LA-NSCLC). 39
Stereotactic body radiotherapy vs conventionally fractionated chemoradiation in locally advanced pancreatic cancer: A multicenter case-control study (PAULA-1) 38
Role of induction therapy in esophageal cancer 38
Radiomics-based prediction of overall survival in lung cancer using different volumes-of-interest 38
Whole-Breast Irradiation: A Subgroup Analysis of Criteria to Stratify for Prone Position Treatment 38
Positron emission tomography with computed tomography imaging (PET/CT) for the radiotherapy planning definition of the biological target volume: PART 1 37
Erlotinib and concurrent chemoradiation in pretreated NSCLC patients: radiobiological basis and clinical results. 37
¹⁸F-choline positron emission tomography/computed tomography-driven high-dose salvage radiation therapy in patients with biochemical progression after radical prostatectomy: feasibility study in 60 patients 37
Somatostatin analogs and disease control in castration-resistant prostate cancer: different biological behavior? Case series and review of the literature 37
Comparative Effectiveness of Chemotherapy Alone Versus Radiotherapy-Based Regimens in Locally Advanced Pancreatic Cancer: A Real-World Multicenter Analysis (PAULA-1) 36
Patterns of radiotherapy practice for pancreatic cancer: Results of the Gastrointestinal Radiation Oncology Study Group multi-institutional survey 36
Stereotactic body radiation therapy for early stage NSCLC: clinical outcomes 35
Totale 10.697
Salva come PNG Salva come JPEG
Categoria #
all - tutte 48.095
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.095
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022117 0 1 2 4 1 3 5 3 13 1 0 84
2022/202379 0 1 2 3 6 1 22 6 7 0 22 9
2023/2024306 11 26 19 15 27 118 14 20 3 17 12 24
2024/20256.558 46 24 146 68 60 116 71 32 279 425 2.420 2.871
2025/20263.837 310 204 233 332 206 223 1.121 206 298 327 201 176
2026/202735 35 0 0 0 0 0 0 0 0 0 0 0
Totale 10.932